Showing results (11-20 of 137) with videos related to

Sort By:
Pageof 14
Pharmacoeconomics|December 8, 2023
A Framework for the Fair Pricing of MedicinesMike Paulden
Health Economics|March 26, 2011
Budget allocation and the revealed social rate of time preference for healthMike Paulden, Karl Claxton
Journal of Health Economics|May 18, 2012
Is a QALY still a QALY at the end of life?Jeff Round
Pharmacoeconomics|January 31, 2021
Modifying NICE's Approach to Equity WeightingMike Paulden, Christopher McCabe
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2014
NICE's selective application of differential discounting: ambiguous, inconsistent, and unjustifiedJames F O'Mahony, Mike Paulden
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 12, 2019
The Joint Committee on Vaccination and Immunisation's Advice on Extending Human Papillomavirus Vaccination to Boys: Were Cost-Effectiveness Analysis Guidelines Bent to Achieve a Politically Acceptable Decision?James F O'Mahony, Mike Paulden
International Journal of Technology Assessment in Health Care|May 21, 2015
MEDICAL DEVICE PRICES IN ECONOMIC EVALUATIONSIlke Akpinar, Philip Jacobs, Don Husereau
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 25, 2016
Determinants of Change in the Cost-effectiveness ThresholdMike Paulden, James O'Mahony, Christopher McCabe
Pharmacoeconomics - Open|February 15, 2018
Statistical Alchemy: Conceptual Validity and Mapping to Generate Health State Utility ValuesJeff Round, Annie Hawton
Pageof 14